Bilaketaren emaitzak - Bermejo, Begoña

Identification of Candidate Polymorphisms on Stress Oxidative and DNA Damage Repair Genes Related with Clinical Outcome in Breast Cancer Patients nork Rodrigues, Patricia, Furriol, Jessica, Bermejo, Begoña, Chaves, Felipe Javier, Lluch, Ana, Eroles, Pilar

Testu osoa Testu osoa Testu osoa

Immunological Landscape of HER-2 Positive Breast Cancer nork Moragon, Santiago, Hernando, Cristina, Martinez-Martinez, Maria Teresa, Tapia, Marta, Ortega-Morillo, Belen, Lluch, Ana, Bermejo, Begoña, Cejalvo, Juan Miguel

Testu osoa Testu osoa Testu osoa

Breast Cancer in Very Young Patients in a Spanish Cohort: Age as an Independent Bad Prognostic Indicator nork Martínez, María Teresa, Oltra, Sara S, Peña-Chilet, María, Alonso, Elisa, Hernando, Cristina, Burgues, Octavio, Chirivella, Isabel, Bermejo, Begoña, Lluch, Ana, Ribas, Gloria

Testu osoa Testu osoa Testu osoa

Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective nork Hernando, Cristina, Ortega-Morillo, Belén, Tapia, Marta, Moragón, Santiago, Martínez, María Teresa, Eroles, Pilar, Garrido-Cano, Iris, Adam-Artigues, Anna, Lluch, Ana, Bermejo, Begoña, Cejalvo, Juan Miguel

Testu osoa Testu osoa Testu osoa

The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors nork Tormo, Eduardo, Ballester, Sandra, Adam-Artigues, Anna, Burgués, Octavio, Alonso, Elisa, Bermejo, Begoña, Menéndez, Silvia, Zazo, Sandra, Madoz-Gúrpide, Juan, Rovira, Ana, Albanell, Joan, Rojo, Federico, Lluch, Ana, Eroles, Pilar

Testu osoa Testu osoa Testu osoa

Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer nork Garrido-Cano, Iris, Constâncio, Vera, Adam-Artigues, Anna, Lameirinhas, Ana, Simón, Soraya, Ortega, Belen, Martínez, María Teresa, Hernando, Cristina, Bermejo, Begoña, Lluch, Ana, Lopes, Paula, Henrique, Rui, Jerónimo, Carmen, Cejalvo, Juan Miguel, Eroles, Pilar

Testu osoa Testu osoa Testu osoa

HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women nork Oltra, Sara S., Cejalvo, Juan Miguel, Tormo, Eduardo, Albanell, Marta, Ferrer, Ana, Nacher, Marta, Bermejo, Begoña, Hernando, Cristina, Chirivella, Isabel, Alonso, Elisa, Burgués, Octavio, Peña-Chilet, Maria, Eroles, Pilar, Lluch, Ana, Ribas, Gloria, Martinez, María Teresa

Testu osoa Testu osoa Testu osoa

MicroRNA-33b Suppresses Epithelial–Mesenchymal Transition Repressing the MYC–EZH2 Pathway in HER2+ Breast Carcinoma nork Pattanayak, Birlipta, Garrido-Cano, Iris, Adam-Artigues, Anna, Tormo, Eduardo, Pineda, Begoña, Cabello, Paula, Alonso, Elisa, Bermejo, Begoña, Hernando, Cristina, Martínez, María Teresa, Rovira, Ana, Albanell, Joan, Rojo, Federico, Burgués, Octavio, Cejalvo, Juan Miguel, Lluch, Ana, Eroles, Pilar

Testu osoa Testu osoa Testu osoa

Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer nork Adam-Artigues, Anna, Garrido-Cano, Iris, Carbonell-Asins, Juan Antonio, Lameirinhas, Ana, Simón, Soraya, Ortega-Morillo, Belén, Martínez, María Teresa, Hernando, Cristina, Constâncio, Vera, Burgues, Octavio, Bermejo, Begoña, Henrique, Rui, Lluch, Ana, Jerónimo, Carmen, Eroles, Pilar, Cejalvo, Juan Miguel

Testu osoa Testu osoa Testu osoa

Detection of TP53 and PIK3CA Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer Diagnosis nork Jimenez Rodriguez, Begona, Diaz Córdoba, Gema, Garrido Aranda, Alicia, Álvarez, Martina, Vicioso, Luis, Llácer Pérez, Casilda, Hernando, Cristina, Bermejo, Begoña, Julve Parreño, Ana, Lluch, Ana, Ryder, Matthew B., Jones, Frederick S., Fredebohm, Johannes, Holtrup, Frank, Queipo-Ortuño, María Isabel, Alba, Emilio

Testu osoa Testu osoa Testu osoa

Association Between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women With Breast Cancer nork Núñez-Torres, Rocío, Martín, Miguel, García-Sáenz, Jose Ángel, Rodrigo-Faus, María, del Monte-Millán, María, Tejera-Pérez, Hugo, Pita, Guillermo, de la Torre-Montero, Julio C., Pinilla, Karen, Herraez, Belén, Peiró-Chova, Lorena, Bermejo, Begoña, Lluch, Anna, González-Neira, Anna

Testu osoa Testu osoa Testu osoa

Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial nork Pascual, Tomás, Oliveira, Mafalda, Villagrasa, Patricia, Ortega, Vanesa, Paré, Laia, Bermejo, Begoña, Morales, Serafín, Amillano, Kepa, López, Rafael, Galván, Patricia, Canes, Jordi, Salvador, Fernando, Nuciforo, Paolo, Rubio, Isabel T., Llombart-Cussac, Antonio, Di Cosimo, Serena, Baselga, José, Harbeck, Nadia, Prat, Aleix, Cortés, Javier

Testu osoa Testu osoa Testu osoa

Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE)() nork Loibl, Sibylle, de la Pena, Lorena, Nekljudova, Valentina, Zardavas, Dimitrios, Michiels, Stefan, Denkert, Carsten, Rezai, Mahdi, Bermejo, Begoña, Untch, Michael, Lee, Soo Chin, Turri, Sabine, Urban, Patrick, Kümmel, Sherko, Steger, Guenther, Gombos, Andrea, Lux, Michael, Piccart, Martine J., Von Minckwitz, Gunter, Baselga, José, Loi, Sherene

Testu osoa Testu osoa Testu osoa

RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast C... nork Baselga, José, Zamagni, Claudio, Gómez, Patricia, Bermejo, Begoña, Nagai, Shigenori E., Melichar, Bohuslav, Chan, Arlene, Mángel, Lászlo, Bergh, Jonas, Costa, Frederico, Gómez, Henry L., Gradishar, William J., Hudis, Clifford A., Rapoport, Bernardo L., Roché, Henri, Patricia, Maeda, Huang, Liping, Meinhardt, Gerold, Zhang, Joshua, Schwartzberg, Lee S.

Testu osoa Testu osoa Testu osoa

Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer—The Evaluating Treatment With Neoadjuvant... nork Gianni, Luca, Mansutti, Mauro, Anton, Antonio, Calvo, Lourdes, Bisagni, Giancarlo, Bermejo, Begoña, Semiglazov, Vladimir, Thill, Marc, Chacon, Jose Ignacio, Chan, Arlene, Morales, Serafin, Alvarez, Isabel, Plazaola, Arrate, Zambetti, Milvia, Redfern, Andrew D., Dittrich, Christian, Dent, Rebecca Alexandra, Magazzù, Domenico, De Fato, Raffaella, Valagussa, Pinuccia, Tusquets, Ignacio

Testu osoa Testu osoa Testu osoa

Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer nork Ocaña, Alberto, Chacón, Jose Ignacio, Calvo, Lourdes, Antón, Antonio, Mansutti, Mauro, Albanell, Joan, Martínez, María Teresa, Lahuerta, Ainhara, Bisagni, Giancarlo, Bermejo, Begoña, Semiglazov, Vladimir, Thill, Marc, Chan, Arlene, Morales, Serafin, Herranz, Jesús, Tusquets, Ignacio, Chiesa, Massimo, Caballero, Rosalía, Valagussa, Pinuccia, Bianchini, Giampaolo, Alba, Emilio, Gianni, Luca

Testu osoa Testu osoa Testu osoa

SOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cance... nork Llombart-Cussac, Antonio, Bermejo, Begoña, Villanueva, Cristian, Delaloge, Suzette, Morales, Serafín, Balmaña, Judith, Amillano, Kepa, Bonnefoi, Hervé, Casas, Ana, Manso, Luis, Roché, Henri, Gonzalez-Santiago, Santiago, Gavilá, Joaquín, Sánchez-Rovira, Pedro, Di Cosimo, Serena, Harbeck, Nadia, Charpentier, Eric, Garcia-Ribas, Ignacio, Radosevic-Robin, Nina, Aura, Claudia, Baselga, Jose

Testu osoa Testu osoa Testu osoa

Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry) nork Lopez-Tarruella, Sara, Escudero, M. J., Pollan, Marina, Martín, Miguel, Jara, Carlos, Bermejo, Begoña, Guerrero-Zotano, Angel, García-Saenz, José, Santaballa, Ana, Alba, Emilio, Andrés, Raquel, Martínez, Purificación, Calvo, Lourdes, Fernández, Antonio, Batista, Norberto, Llombart-Cussac, Antonio, Antón, Antonio, Lahuerta, Ainhara, de la Haba, Juan, López-Vega, José Manuel, Carrasco, E.

Testu osoa Testu osoa Testu osoa

Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial nork Quintela-Fandino, Miguel, Holgado, Esther, Manso, Luis, Morales, Serafin, Bermejo, Begoña, Colomer, Ramon, Apala, Juan V., Blanco, Raquel, Muñoz, Manuel, Caleiras, Eduardo, Iranzo, Vega, Martinez, Mario, Dominguez, Orlando, Hornedo, Javier, Gonzalez-Cortijo, Lucia, Cortes, Javier, Gasol Cudos, Ariadna, Malon, Diego, Lopez-Alonso, Antonio, Moreno-Ortíz, María C., Mouron, Silvana, Mañes, Santos

Testu osoa Testu osoa Testu osoa

The TRAR gene classifier to predict response to neoadjuvant therapy in HER2‐positive and ER‐positive breast cancer patients: an explorative analysis from the NeoSphere trial nork Triulzi, Tiziana, Bianchini, Giampaolo, Di Cosimo, Serena, Pienkowski, Tadeusz, Im, Young‐Hyuck, Bianchi, Giulia Valeria, Galbardi, Barbara, Dugo, Matteo, De Cecco, Loris, Tseng, Ling‐Ming, Liu, Mei‐Ching, Bermejo, Begoña, Semiglazov, Vladimir, Viale, Giulia, de la Haba‐Rodriguez, Juan, Oh, Do‐Youn, Poirier, Brigitte, Valagussa, Pinuccia, Gianni, Luca, Tagliabue, Elda

Testu osoa Testu osoa Testu osoa